McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
The change from Baseline in the Adult ADHD Investigator Symptom Rating Scale (AISRS) total score as assessed by the Investigator at the Final Visit/2 Week Efficacy Assessment Visit
Change from baseline in the AISRS as completed by the Investigator at each Titration Visit. Change from baseline in the AISRS as completed by the Investigator at the end of the study or the last score provided during the study by mg/kg dosing groups.
18 Years to 65 Years (Adult)
May 16, 2006
May 24, 2011
† Study has passed its completion date and status has not been verified in more than two years.